NCT00796185View on ClinicalTrials.gov

As Study of the Pharmacokinetics of Paliperidone Extended-release and Risperidone Immediate-release Formulations

PHASE1CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

August 31, 2003

Study Completion Date

January 31, 2004

Conditions
SchizophreniaSchizoaffective Disorder
Interventions
DRUG

Paliperidone ER

All Listed Sponsors
lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00796185 - As Study of the Pharmacokinetics of Paliperidone Extended-release and Risperidone Immediate-release Formulations | Biotech Hunter | Biotech Hunter